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Background: Infection is the most common precipitating factor and cause of death in patients with hyperglycemic
crises. Treating infection-precipitated hyperglycemic crises includes using empiric antibiotics early; correcting
dehydration, hyperglycemia, and electrolyte imbalances; and frequent monitoring. Intensive care unit admission,
broad-spectrum antibiotics, and even novel therapy for infection may be beneficial for patients with a high risk of
mortality. However, these management options are costly and not beneficial for every patient. Selecting high-risk
patients who would most likely benefit is more appropriate. We investigated the independent mortality predictors
of patients with infection-precipitated hyperglycemic crises to facilitate clinical decision making.
Methods: This study was conducted in a university-affiliated medical center. Consecutive adult patients (> 18 years old)
visiting the Emergency Department between January 2004 and December 2010 were enrolled when they met the
criteria of an infection-precipitated hyperglycemic crisis. Thirty-day mortality was the primary endpoint.
Results: One hundred forty-two patients were enrolled. The infection source did not predict mortality. The presenting
variables that were independently associated with 30-day mortality in a multiple logistic regression model were cancer
history (odds ratio [OR], 7.4; 95% confidence interval [CI], 2.4-23.2), bandemia (OR, 7.0; 95% CI, 1.6-30.3), and serum
creatinine (OR, 1.4; 95% CI, 1.1-1.8). The common sources of infection were the lower respiratory tract (30.3%), urinary
tract (49.3%), skin or soft tissue (12.0%), and intra-abdominal (6.3%).
Conclusions: Cancer history, bandemia, and serum creatinine level are three independent mortality predictors for
patients with infection-precipitated hyperglycemic crises. These predictors are both readily available and valuable for
physicians making decisions about risk stratification, treatment, and disposition.
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Hyperglycemic crises present a disease continuum of dia-
betic emergency. The basic underlying mechanism is the
combination of absolute or relative insulin deficiency and
an increase in counter regulatory hormones: glucagon, cate-
cholamines, cortisol, and growth hormone [1]. There are
three types of hyperglycemic crisis: (a) diabetic ketoacidosis
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reproduction in any medium, provided the orb are two extremes of the same clinical syndrome), and (c)
mixed syndrome (both DKA and HHS as a mixed state of
acidosis and hyperosmolality) [2-7].
Despite recent improvements, the incidence and the
cost of treating hyperglycemic crises are high and con-
tinue to rise. The annual DKA incidence rate has been
estimated in population-based studies to range from 4.6
to 8 episodes per 1,000 patients with diabetes, and recent
epidemiological studies in the U.S. report that the annual
DKA incidence rate sharply increased during the past two
decades [3]. In 2006, there were about 136,510 hospitali-
zations for DKA in the U.S. [8]. The average cost per pa-
tient per hospitalization was US$13,000, and the annualLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with DKA might exceed US$1 billion [3]. The incidence
of and medical expenditure for HHS care are unknown
because there are few population-based studies on HHS,
and because many patients with HHS have multiple
comorbidities. The rate of hospital admissions for HHS
was estimated more than a decade ago to be 1% of all
primary diabetic admissions [9]. The mortality rate for
hyperglycemic crises remains high: 1-9% for DKA, 5-45%
for HHS, and 5-25% for mixed DKA/HHS [1,4,5]. Among
the elderly (≥ 65 years old), the mortality rate was recently
reported to be as high as 71% [10].
Infection is the most common precipitating factor in
patients with hyperglycemic crises. Estimates range from
32% to 60%, with urinary tract infection, pneumonia, and
sepsis as the most frequent types [11]. Other precipitating
factors are inadequate or inappropriate therapy, pancrea-
titis, myocardial infarction, cerebrovascular accident, and
drugs [1]. Infection is also the most common (67-80%)
cause of death [5,12,13]. Therefore, investigating and
treating infection is the first priority when a patient pre-
sents with a hyperglycemic crisis. Thresholds for blood
cultures and empiric antibiotics should be low because
the manifestation of infection may be unapparent, espe-
cially in long-term diabetes and in elderly patients [1,14].
Treating infection-precipitated hyperglycemic crises
includes using empiric antibiotics early; correcting de-
hydration, hyperglycemia, and electrolyte imbalances; and
frequent monitoring [1]. Intensive care unit admission,
broad-spectrum antibiotics, and even novel therapy for
infection may be beneficial for patients with a high risk
of mortality [15]. However, these management options
are costly and not beneficial for every patient. Selecting
high-risk patients who would most likely benefit is more
appropriate. There is no published study about this,
however. Therefore, our goals were to (i) identify univariate
correlates of death in patients with infection-precipitated
hyperglycemic crises, and (ii) identify independent mortality
predictors that may help clinical decision making.
Methods
Study design, setting, population, and selection
of participants
This study was done in a 700-bed university-affiliated med-
ical center in Taipei with a 40-bed emergency department
(ED) staffed with board-certified emergency physicians who
provide emergency care to approximately 55,000 patients
per year. Consecutive adult patients (> 18 years old) visiting
the ED between January 2004 and December 2010 were
enrolled when they met the following criteria [11]: (i) DKA
was defined as casual plasma glucose > 250 mg/dL, a
high anion gap metabolic acidosis (anion gap > 10, serum
HCO3 < 18 mmol/L, and pH < 7.3), and positive urine
ketones or serum ketones; (ii) HHS was defined as casualplasma glucose > 600 mg/dL, increased effective serum
osmolality > 320 mOsm/kg, anion gap < 12, no signifi-
cant acidosis (HCO3 > 15 mmol/L or pH > 7.3), small
urine ketones or serum ketones, and alteration in mental
state; (iii) Mixed syndrome (DKA plus HHS) was defined
as acidosis (pH < 7.3, HCO3 < 18 mmol/L), positive urine
ketones or serum ketones, and effective serum osmolality
> 320 mosm/kg. The effective serum osmolality was calcu-
lated using the formula:
2 measured Naþ mEq=Lð Þ½  þ glucose mg=dLð Þ½ =18 11½ 
The definition of infection included lower respiratory
tract infection, urinary tract infection, intra-abdominal
infection, skin or soft tissue infection, meningitis, bone/
joint infection, perianal abscess, psoas muscle abscess,
and sepsis without focus. The clinical impression of infec-
tion was based on the diagnoses of the treating physician’s
documentation, laboratory, and image results (such as
pneumonia on a chest radiograph, pyuria on a urinary
analysis, abscess on computed tomography, etc.).
Data collection and definition of variables
All treatment of hyperglycemic crises in the studied hos-
pital is strictly according to the guidelines suggested by
the American Diabetes Association [1,3,11]. Patients were
prospectively selected in the ED. Insufficient information
was retrospectively collected by reviewers checking med-
ical records after the patients had been discharged from
the hospital. The studied hospital’s Human Investigation
Committee approved the protocol. The reviewers were
blinded to the patients’ hospital courses and outcomes.
Information for a number of variables for each patient
was recorded (Tables 1 and 2). Cancer history was de-
fined as any mention of metastatic or non-metastatic
cancer in a patient’s medical records. Bandemia was de-
fined as greater than 10% band forms [16]. Any variable
not noted in history or physical exam as present was
considered to be absent.
The enrolled patients were divided into two groups
based on their 30-day outcome: (i) 30-day mortality and
(ii) survival. All the study variables were used for com-
parisons between groups.
Definition of endpoint
We used the 30-day mortality as the primary endpoint.
People who survived at least 30 days whether or not they
were still hospitalized were considered “survival” for this
analysis.
Data analysis
All analyses were done using SPSS 16.0 for Windows
(SPSS Inc., Chicago, IL, USA). Continuous data are means ±
SD. Comparisons between two groups were made using
Table 1 Univariate analysis of clinical variables of 142 patient visits with hyperglycemic crises precipitated by infection
Variable Survival (n = 115) 30-day mortality (n = 27) P-value All (n = 142)
Age, mean ± SD 67.5 ± 17.1 72.4 ± 19.7 0.200 68.4 ± 17.6
Elderly (≥ 65 years old), % 62.6 81.5 0.073 66.2
Gender: Male, % 37.4 48.1 0.303 39.4
Altered mental status, % 53.0 77.8 0.029 57.7
SBP, mean ± SD 135.0 ± 32.0 127.5 ± 36.7 0.289 133.6 ± 32.9
Heart rate, mean ± SD 118.1 ± 21.3 106.0 ± 26.3 0.013 115.8 ± 22.8
Body temperature, mean ± SD 37.3 ± 1.2 37.1 ± 1.4 0.387 37.2 ± 1.2
Respiratory rate, mean ± SD 22.1 ± 6.1 21.9 ± 6.5 0.898 22.1 ± 6.1
Medical history, %
Hypertension 53.9 48.1 0.589 52.8
Diabetes 82.6 88.9 0.567 83.8
Stroke 33.0 33.3 >0.95 33.1
Chronic renal insufficiency 14.8 25.9 0.166 16.9
Cancer 7.8 29.6 0.005 12.0
Bedridden 20.0 25.9 0.600 21.1
Infection source, %*
Low respiratory tract 31.3 25.9 0.649 30.3
Urinary tract 52.2 37.0 0.157 49.3
Skin or soft tissue 10.4 18.5 0.319 12.0
Intra-abdominal 5.2 11.1 0.372 6.3
Meningitis 0.9 0.0 >0.95 0.7
Bone/joint 0.9 0.0 >0.95 0.7
Perianal abscess 0.0 3.7 0.190 0.7
Psoas muscle abscess 0.9 0.0 >0.95 0.7
Sepsis without focus 0.9 0.0 >0.95 0.7
Subgroup diagnosis, %
DKA 22.6 14.8 0.443 21.1
HHS 64.3 66.7 >0.95 64.8
Mixed DKA/HHS 13.0 18.5 0.538 14.1
SD standard deviation, SBP systolic blood pressure, DKA diabetic ketoacidosis, HHS hyperosmolar hyperglycemic state.
*Patient may have multiple infection sources.
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distribution) or Mann–Whitney/Wilcoxon tests (assum-
ing non-normality) for the continuous variables. Either
a χ2 test or a Fisher’s exact test was used for categorical
variables. One-way ANOVA was used in comparisons
between the subgroups of hyperglycemic crises. The vari-
ables in the univariate comparison (P < 0.1) were then in-
cluded in a multiple logistic regression analysis of risk for
30-day mortality. Statistical significance was set at P < 0.05
(two tailed).
Results
During our study period, 160 patients with hyperglycemic
crises precipitated by infection presented to the ED.Eighteen were excluded from the study because of insuf-
ficient data or because they had been treated in an-
other hospital.
The final study cohort consisted of 142 patients (56
[39.4%] men, 86 women [60.6%] age range: 19 to 93 years
old; mean age ± SD: 68.4 ± 17.6 years; median: 73 years)
(Table 1). Twenty-seven (19%) of them died within 30 days.
The percentages of DKA, HHS, and mixed DKA/HHS
were 30/142 (21.1%), 92/142 (64.8%), and 20/142 (14.1%),
respectively. The distribution of DKA, HHS, and mixed
DKA/HHS among survivors and 30-day mortality was
showed in Figure 1.
Univariate analysis was used to compare survival and
30-day mortality (Table 1). The common sources of
Table 2 Univariate analysis of biochemical variables of 142 patient visits with hyperglycemic crises precipitated
by infection
Variable Survival (n = 115) 30-day mortality (n = 27) P-value All (n = 142)
Laboratory data, mean ± SD
Blood glucose (mg/dL) 739.9 ± 311.0 757.3 ± 259.8 0.788 743.2 ± 301.1
WBC (cells/mm3) 15300.0 ± 6406 13700.0 ± 5909 0.250 15000.0 ± 6324
Hemoglobin (g/dL) 13.1 ± 2.6 12.5 ± 3.0 0.314 12.9 ± 2.7
Platelet (1000/mm3) 247.5 ± 103.1 203.5 ± 82.2 0.041 239.2 ± 100.7
Osmolarity (mOsm/kg)* 335.6 ± 33.0 335.4 ± 28.6 >0.95 346.5 ± 34.5
Serum creatinine (mg/dL) 2.2 ± 1.4 3.3 ± 2.7 0.046 2.4 ± 1.8
Blood pH† 7.4 ± 0.1 7.3 ± 0.2 0.208 7.4 ± 0.1
HbA1c (%)‡ 11.2 ± 3.2 10.1 ± 2.7 0.183 11.0 ± 3.1
Bandemia (> 10% band), % 4.3 14.8 0.047 6.3
SD standard deviation, WBC white blood cell count.
*Effective serum osmolarity: 2[measured Na+ (mEq/L)] + [glucose (mg/dL)]/18.
†90.1% (128/142) patients had this test.
‡72.2% (83/115) survival patients had this test; 66.7% (18/27) 30-day mortality patients had this test.
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(49.3%), skin or soft tissue (12.0%), and intra-abdominal
(6.3%). Multiple logistic regression modeling was then
done using the univariate comparison P < 0.1 (Tables 1,
2, 3). The infection source did not predict mortality. The
presenting variables independently associated with 30-day
mortality in the multiple logistic regression model were
cancer history (odds ratio [OR], 7.4; 95% confidence inter-
val [CI], 2.4-23.2), bandemia (OR, 7.0; 95% CI, 1.6-30.3),
and serum creatinine (OR, 1.4; 95% CI, 1.1-1.8).
Discussion
This study delineated independent mortality predictors
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Figure 1 Comparison of patient number of DKA, HHS, and
mixed DKA/HHS among survivors and 30-day mortality.by infection. Multiple logistic regression analysis showed
that cancer history, bandemia, and serum creatinine level
were the independent mortality predictors. These pre-
dictors, readily available to physicians, can provide valu-
able information for the risk stratification, treatment,
and disposition of patients. For patients with more mor-
tality predictors, aggressive intervention—intensive care
unit (ICU) admission, fluid resuscitation, source identi-
fication and control, broad-spectrum antibiotics, and
novel therapy for infection such activated protein C
should be considered [15,17].
Metastatic cancer has been used as a mortality predictor
in ICU mortality scores such as the MPM (Mortality
Probability Model), SAPS (Simplified APACHE Score),
and APACHE (Acute Physiology and Chronic Health
Evaluation) [18]. In this study, “cancer history” included
the presence of any malignancy, whether metastatic or
non-metastatic. We found that this “cancer history” vari-
able was a better predictor than was metastatic cancer.
Elevated serum creatinine indicates a poor prognosis,
which is more likely due to renal impairment rather than
infection. Bandemia refers to an excess of band cells
(immature white blood cells) released by the bone mar-
row into the blood. It signifies infection (or sepsis) or
inflammation. A band level > 10% is a criterion of sepsis
[16] and has been identified as a mortality predictor in
sepsis [19]. We also found that it was an accurate pre-
dictor of mortality.
In clinical practice, blood PH and effective serum
osmolality are important for evaluating hyperglycemic
crises. Interestingly, these two factors were not mortality
predictors (Table 2). In other words, more acidosis and
higher osmolality do not correlate with a poorer outcome.
In previous studies [1,4,5], the mortality rates of the
three different types of hyperglycemic crisis (DKA, HHS,
Table 3 Multivariate logistic regression modeling using a univariate comparison (P < 0.1)
Variable Odds ratio (95% Confidence Interval) P-value
Full model Final model
Cancer history 4.5 (1.3-15.4) 7.4 (2.4-23.2) 0.001
Bandemia (> 10% band) 6.2 (1.1-33.1) 7.0 (1.6-30.3) 0.010
Serum creatinine 1.4 (1.1-1.7) 1.4 (1.1-1.8) 0.007
Elderly (≥ 65 years old) 2.1 (0.6-7.5) NA
Altered mental status 2.6 (0.8-8.2) NA
Heart rate 0.9 (0.8-1.0) NA
Platelet (1000/mm3) 0.9 (0.8-1.0) NA
NA not available; variable not included in the final model.
Huang et al. BMC Endocrine Disorders 2013, 13:23 Page 5 of 6
http://www.biomedcentral.com/1472-6823/13/23and mixed syndrome DKA/HHS) were different. In the
present study, the overall 30-day mortality rates of DKA,
HHS, and mixed syndrome DKA/HHS were 4/30 (13.3%),
18/92 (19.6%), and 5/20 (25%), respectively. We found dif-
ferences in mortality similar to the literature but this did
not reach statistical significance, likely due to small group
sizes. The subgroup diagnosis was also not a mortality
predictor.
The causes of death were further analyzed. Most of the
patients died from infection (25/27; 92.6%), not the hyper-
glycemic crisis itself. Two patients died from ventricular
arrhythmia related to hypokalemia; both were young (23
and 26 years old) women with type 1 diabetes.
This study has several limitations. First, some data
were collected from a retrospective chart review. These
clinical presentations or records may not have been com-
pletely documented. Second, this was a single-center study.
Findings from our database may not be generalizable to
other cohorts in Taiwan or in other nations. Third, the
interpretation of infection in an early stage may be dif-
ferent between physicians. In a busy ED with a short
patient stay, suspected infection by the treating phys-
ician along with laboratory and image result is more
practical than confirmed infection. Fourth, there is a dra-
matically high prevalence of HHS relative to DKA in this
population and this may be why the pH did not correlate
with death, since the majority in this small cohort did not
have acidosis. In our previous study of the same popula-
tion [20], DKA constituted 31.5% of all hyperglycemic
crises, which was compatible with the observations by
Wachtel et al. in Rhode Island [2] and by Chung et al.
in Jamaica [4]. Therefore, the high prevalence of HHS
relative to DKA may be due to the fact that this study
enrolled a subgroup of patients who had infection-
precipitated hyperglycemic crises, and therefore the ratio
of HHS to DKA cases was not the same as in the whole
patient population. Fifth, the number of patients might
have been too small to draw any firm conclusions, and
further study with a much larger study population will be
necessary to clarify this issue.Conclusions
Cancer history, bandemia, and serum creatinine level are in-
dependent mortality predictors for patients with infection-
precipitated hyperglycemic crises. These predictors are
both readily available and valuable for physicians making
decisions about risk stratification, treatment, and disposition.
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